Cargando…
Remodeling of Stromal Immune Microenvironment by Urolithin A Improves Survival with Immune Checkpoint Blockade in Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDAC) is a significant contributor to cancer-related morbidity and mortality, and it is known for its resistance to conventional treatment regimens, including chemotherapy and immune checkpoint blockade (ICB)-based therapies. We have previously shown that Urolithin...
Autores principales: | Mehra, Siddharth, Garrido, Vanessa T., Dosch, Austin R., Lamichhane, Purushottam, Srinivasan, Supriya, Singh, Samara P., Zhou, Zhiqun, De Castro Silva, Iago, Joshi, Chandrashekar, Ban, Yuguang, Datta, Jashodeep, Gilboa, Eli, Merchant, Nipun B., Nagathihalli, Nagaraj S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337606/ https://www.ncbi.nlm.nih.gov/pubmed/37448553 http://dx.doi.org/10.1158/2767-9764.CRC-22-0329 |
Ejemplares similares
-
Deciphering high risk molecular alterations in gastrointestinal malignancy utilizing an extreme outlier strategy
por: Dosch, Austin R., et al.
Publicado: (2020) -
Ras-p53 genomic cooperativity as a model to investigate mechanisms of innate immune regulation in gastrointestinal cancers
por: Dosch, Austin R., et al.
Publicado: (2021) -
Emerging Role of CREB in Epithelial to Mesenchymal Plasticity of Pancreatic Cancer
por: Mehra, Siddharth, et al.
Publicado: (2022) -
New mechanistic insights into modifiable risk factors that promote pancreatic cancer
por: Srinivasan, Supriya, et al.
Publicado: (2019) -
Emerging targets in pancreatic cancer: epithelial–mesenchymal transition and cancer stem cells
por: Castellanos, Jason A, et al.
Publicado: (2013)